Crossmark

Identification of Aristolactam Derivatives That Act as Inhibitors of Human Immunodeficiency Virus Type 1 Infection and Replication by Targeting Tat-Mediated Viral Transcription

Crossref DOI link: https://doi.org/10.1007/s12250-020-00274-7

Published Online: 2020-08-10

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shin, YoungHyun

Park, Chul Min

Kim, Hong Gi

Kim, Dong-Eun

Choi, Min Suk

Kim, Jeong-ah

Choi, Byeong-Sun

Yoon, Cheol-Hee https://orcid.org/0000-0002-5696-0567
License Information

Text and Data Mining valid from 2020-08-10

Version of Record valid from 2020-08-10
More Information

Article History

Received: 15 May 2020

Accepted: 28 June 2020

First Online: 10 August 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below